Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation

Qing Hui Zhou, Douglas L. Miller, Robert C. Carlisle, Leonard W. Seymour, David Oupicky

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Cancer gene therapy would greatly benefit from the possibility to deliver therapeutic genes via tumor-targeted systemic intravenous delivery. The main objective of this study was to determine biophysical, transfection, and pharmacokinetic properties of DNA complexes with reducible polycations that are reversibly stabilized by surface coating with multivalent HPMA copolymers. The specific goals were to evaluate compatibility of these polyplexes with extended plasma circulation, molecular targeting, and ultrasound-enhanced transfection activity. It was demonstrated that using polyplexes based on reducible polycations allows increasing transfection activity and preserving extended plasma circulation half-life observed for control polyplexes based on non-reducible polycations. In addition, the reversibly stabilized polyplexes were compatible with both molecular targeting using protein ligands as well as physical targeting using ultrasound-directed cavitation in vitro. As such, the described gene delivery vectors have the potential to permit efficient systemic delivery of therapeutic genes targeted by a local focused ultrasound treatment.

Original languageEnglish (US)
Pages (from-to)416-427
Number of pages12
JournalJournal of Controlled Release
Issue number3
StatePublished - Sep 2 2005
Externally publishedYes


  • Gene delivery
  • In vivo
  • Polyplex
  • Transfection
  • Ultrasound

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation'. Together they form a unique fingerprint.

Cite this